An economically rational method of managing early-stage endometriosis.

Eric S. Surrey, E Surrey, Surrey E
Medical interface · 1997 · vol. 10(3) , pp. 119–24 · PMID:10172946 · W2463113929
article OA: closed CC0 ⤵ 5 in-corpus citations
View on OpenAlex View on PubMed
⚙ AI-generated summary by gemini-2.5-flash-lite, 2026-07-09 ⓘ

This paper outlines the cost-effectiveness of a trial course of GnRH agonists as a management strategy for women presenting with chronic pelvic pain and early-stage endometriosis.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis is a common gynecologic disease among women of reproductive age. The lesions of early endometriosis may be missed during laparoscopy, which has been considered to be the definitive means of both diagnosis and treatment. Moreover, laparoscopic treatment of minimal-to-mild (stage 1 to 2) endometriosis does not always resolve associated chronic pelvic pain in many women. Instead, medical therapy with gonadotropin-releasing hormone (GnRH) agonists may be more effective in providing long-lasting pain relief in patients with similar disease stages. The author outlines the cost effectiveness of a trial course of GnRH agonists in women presenting with chronic pelvic pain.

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_pain

MeSH descriptors

Endometriosis Gonadotropin-Releasing Hormone Health Care Costs Hormone Antagonists Laparoscopy Cost-Benefit Analysis Diagnosis, Differential Endometriosis Endometriosis Endometriosis Endometriosis Female Gonadotropin-Releasing Hormone Hormone Antagonists Hormone Antagonists Humans Laparoscopy Pelvic Pain Pelvic Pain United States

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (5)

Source provenance

europepmc
last seen: 2026-09-03T06:15:13.668130+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:10:52.568893+00:00
License: CC0 · commercial use OK